Related Experiment Videos
Therapy of livedo vasculitis with pentoxifylline
Cutis
|November 1, 1988
Summary
Pentoxifylline effectively treated two patients with idiopathic livedo vasculitis. This medication offers multiple benefits, including improved blood flow and reduced clotting, making it a promising therapy for this condition.
Area of Science:
- Vascular Medicine
- Dermatology
- Pharmacology
Background:
- Idiopathic livedo vasculitis is a rare condition causing skin lesions due to abnormal blood vessel function.
- Previous treatments, like fibrinolytic therapy, showed limited success or were withdrawn from the market.
Observation:
- Two patients with idiopathic livedo vasculitis were treated with pentoxifylline.
- One patient had a history of positive response to phenformin and ethylestrenol before phenformin became unavailable.
Findings:
- Pentoxifylline therapy resulted in a favorable response in both patients.
- The drug's mechanisms include stimulating prostacyclin synthesis, reducing platelet aggregation, enhancing red blood cell deformability, increasing neutrophil mobility, and promoting fibrinolysis.
Implications:
- Pentoxifylline presents a viable therapeutic option for managing idiopathic livedo vasculitis.
- Its multifaceted action on hemorheology and vascular function may explain its efficacy in this vasculitic condition.